CorMedix Therapeutics to Participate in the Wells Fargo Healthcare Conference
PARSIPPANY, N.J., Sept. 01, 2026 (GLOBE NEWSWIRE) -- CorMedix Therapeutics (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced that senior management will be participating in a fireside chat and investor meetings at the upcoming Wells Fargo 21st Annual Healthcare Conference being held in Boston on September 8 – 10, 2026.
Covered in this story
What has happened since
- Cormedix Inc is down 3.3% since this was published, 51 days ago.
- Wells Fargo is down 4.6% since this was published, 51 days ago.
Price move measured from the close nearest publication to the latest quote.
Call it yourself
No calls on $CRMD yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Cormedix Inc →Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.